Taylor M Coe1, Zhi Ven Fong2, Samuel E Wilson3, Mark A Talamini4, Keith D Lillemoe2, David C Chang5. 1. School of Medicine, University of California, San Diego, La Jolla, CA, USA. 2. Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. 3. Department of Surgery, Irvine Medical Center, University of California, Irvine, Orange, CA, USA. 4. Department of Surgery, SUNY Stony Brook, Stony Brook, NY, USA. 5. Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. dchang8@mgh.harvard.edu.
Abstract
BACKGROUND: Most studies on learning curves for pancreaticoduodenectomy have been based on single-surgeon series at tertiary academic centers or are inferred indirectly from volume-outcome relationships. Our aim is to describe mortality rates associated with cumulative surgical experience among non-teaching hospitals. STUDY DESIGN: Observational study of a statewide inpatient database. Analysis included hospitals that began performing pancreaticoduodenectomy between 1996 and 2010, as captured by the California Office of Statewide Health Planning and Development database. Cases were numbered sequentially within each hospital. The same sequential series (e.g., first 10 cases, 11th through 20th cases) were identified across hospitals. The outcome measure was in-hospital mortality. RESULTS: A total of 1210 cases from 143 non-teaching hospitals were analyzed. The average age was 63 years old, and the majority of patients were non-Hispanic white. The median overall mortality rate was 9.75 %. The mortality rate for the first 10 aggregated cases was 11.3 %. This improved for subsequent cases, reaching 7.1 % for the 21st-30th cases. However, the mortality rate then increased, reaching 16.7 % by the 41st-50th cases before falling to 0.0 % by the 61st-70th cases. CONCLUSIONS: Initial improvement in surgical outcomes relative to cumulative surgical experience is not sustained. It is likely that factors other than surgical experience affect outcomes, such as less rigorous assessment of comorbidities or changes in support services. Vigilance regarding outcomes should be maintained even after initial improvements.
BACKGROUND: Most studies on learning curves for pancreaticoduodenectomy have been based on single-surgeon series at tertiary academic centers or are inferred indirectly from volume-outcome relationships. Our aim is to describe mortality rates associated with cumulative surgical experience among non-teaching hospitals. STUDY DESIGN: Observational study of a statewide inpatient database. Analysis included hospitals that began performing pancreaticoduodenectomy between 1996 and 2010, as captured by the California Office of Statewide Health Planning and Development database. Cases were numbered sequentially within each hospital. The same sequential series (e.g., first 10 cases, 11th through 20th cases) were identified across hospitals. The outcome measure was in-hospital mortality. RESULTS: A total of 1210 cases from 143 non-teaching hospitals were analyzed. The average age was 63 years old, and the majority of patients were non-Hispanic white. The median overall mortality rate was 9.75 %. The mortality rate for the first 10 aggregated cases was 11.3 %. This improved for subsequent cases, reaching 7.1 % for the 21st-30th cases. However, the mortality rate then increased, reaching 16.7 % by the 41st-50th cases before falling to 0.0 % by the 61st-70th cases. CONCLUSIONS: Initial improvement in surgical outcomes relative to cumulative surgical experience is not sustained. It is likely that factors other than surgical experience affect outcomes, such as less rigorous assessment of comorbidities or changes in support services. Vigilance regarding outcomes should be maintained even after initial improvements.
Authors: Craig R Ramsay; Sheila A Wallace; Paul H Garthwaite; Andrew F Monk; Ian T Russell; Adrian M Grant Journal: Int J Technol Assess Health Care Date: 2002 Impact factor: 2.188
Authors: William E Fisher; Sally E Hodges; Meng-Fen Wu; Susan G Hilsenbeck; F Charles Brunicardi Journal: Am J Surg Date: 2011-11-09 Impact factor: 2.565
Authors: Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo Journal: J Gastrointest Surg Date: 2006-11 Impact factor: 3.452
Authors: Zhi Ven Fong; Camilo Correa-Gallego; Cristina R Ferrone; Gregory R Veillette; Andrew L Warshaw; Keith D Lillemoe; Carlos Fernández-del Castillo Journal: Ann Surg Date: 2015-08 Impact factor: 12.969
Authors: Jennifer F Tseng; Peter W T Pisters; Jeffrey E Lee; Huamin Wang; Henry F Gomez; Charlotte C Sun; Douglas B Evans Journal: Surgery Date: 2007-01-22 Impact factor: 3.982
Authors: Bolanle Asiyanbola; David Chang; Ana Luiza Gleisner; Hari Nathan; Michael A Choti; Richard D Schulick; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2008-02-12 Impact factor: 3.452
Authors: Vincenzo Villani; Jordan D Bohnen; Radbeh Torabi; Francesco Sabbatino; David C Chang; Cristina R Ferrone Journal: HPB (Oxford) Date: 2016-04-26 Impact factor: 3.647
Authors: Zhi Ven Fong; Pei-Wen Lim; Ryan Hendrix; Carlos Fernandez-Del Castillo; Ryan D Nipp; James M Lindberg; Giles F Whalen; William Kastrinakis; Motaz Qadan; Cristina R Ferrone; Andrew L Warshaw; Keith D Lillemoe; David C Chang; Lara N Traeger Journal: Ann Surg Oncol Date: 2021-01-07 Impact factor: 4.339